Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Prestige Consumer Healthcare (PBH) Shares Outstanding (Diluted Average) (2016 - 2025)

Prestige Consumer Healthcare has reported Shares Outstanding (Diluted Average) over the past 16 years, most recently at $48.1 million for Q4 2025.

  • Quarterly results put Shares Outstanding (Diluted Average) at $48.1 million for Q4 2025, down 3.81% from a year ago — trailing twelve months through Dec 2025 was $48.1 million (down 3.81% YoY), and the annual figure for FY2025 was $50.1 million, changed 0.2%.
  • Shares Outstanding (Diluted Average) for Q4 2025 was $48.1 million at Prestige Consumer Healthcare, down from $49.3 million in the prior quarter.
  • Over the last five years, Shares Outstanding (Diluted Average) for PBH hit a ceiling of $50.8 million in Q1 2022 and a floor of $48.1 million in Q4 2025.
  • Median Shares Outstanding (Diluted Average) over the past 5 years was $50.2 million (2023), compared with a mean of $50.2 million.
  • Biggest five-year swings in Shares Outstanding (Diluted Average): increased 0.58% in 2024 and later fell 3.81% in 2025.
  • Prestige Consumer Healthcare's Shares Outstanding (Diluted Average) stood at $50.8 million in 2021, then fell by 0.8% to $50.4 million in 2022, then dropped by 0.51% to $50.1 million in 2023, then decreased by 0.28% to $50.0 million in 2024, then dropped by 3.81% to $48.1 million in 2025.
  • The last three reported values for Shares Outstanding (Diluted Average) were $48.1 million (Q4 2025), $49.3 million (Q3 2025), and $49.8 million (Q2 2025) per Business Quant data.